Glooko has filed a notice of an exempt offering of securities to raise $67 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Glooko is raising $67,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Russ Johannesson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Glooko
Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials. Glooko is globally deployed in over 30 countries and 8,000+ clinical locations.
To learn more about Glooko, visit http://www.glooko.com/
Contact:
Russ Johannesson, Chief Executive Officer
650-720-5310
https://www.linkedin.com/in/russjohannesson/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.